Procter & Gamble Has Raised Its Dividend for 70 Straight Years. Here's Why That Matters in a Sell-Off

Procter & Gamble's fiscal 2026 free cash flow rose 8% to $15.1 billion, covering $10.2 billion in dividends; it also repurchased $5.0 billion of shares. For fiscal 2027, P&G forecasts organic sales growth of 1%-3% and core EPS growth of 0%-3%, with more than $10 billion planned for dividends and another $5 billion for buybacks. Growth has cooled amid inflationary pressure and weaker performance in China and North America; at $160, the stock trades at 23 times the midpoint of its fiscal 2027 core EPS forecast, which the article describes as somewhat high relative to growth potential.

Analysis

The key tension is not dividend safety but the price paid for safety: at roughly 23x FY27 midpoint core EPS against 0–3% expected EPS growth, PG has limited room for execution misses if investors demand a higher equity risk premium. The “defensive” label is not a one-way hedge: in a rate shock, higher real yields can compress a bond-proxy multiple even as recession fears support staples. That makes PG more useful as a lower-beta holding than as crash insurance.

The second-order risk is volume elasticity. Repeated price increases can protect near-term sales dollars while encouraging private-label substitution or trade-down, especially where household budgets are tight. Watch organic volume and price/mix separately; premiumization only offsets this if consumers accept higher price points without sacrificing units. This pressure could also benefit value-focused retailers and lower-priced competitors, while brands with stronger pricing power may hold up better.

Over the next 1–3 months, the test is whether guidance stabilization appears in volume and regional demand, not just pricing. Over 6–18 months, persistently weak units would challenge the growth premium and make buybacks less effective as an EPS support if valuation remains elevated. The article’s >100% FCF payout through dividends and repurchases warrants checking cash/debt movements before assuming the full pace is repeatable. A sustained volume recovery and stable real yields would falsify the cautious valuation view.

Key Decisions for Investors

• Do not add PG solely as a crash hedge at the stated valuation. For existing holders, keep the position sized as a defensive quality exposure, but consider trimming into strength if real yields rise and organic volume remains weak.
• Watch the next results for organic volume versus price/mix, North America and China trends, and the cash-flow bridge after dividends and buybacks. A further deterioration in units or reduced capital returns would strengthen the underweight case; volume stabilization with guidance maintained would weaken it.
• Relative-value watch, not yet a pair recommendation: compare PG’s valuation and volume trajectory with Procter & Gamble’s staples peers, including Unilever, Colgate-Palmolive, Kimberly-Clark, and Church & Dwight, before rotating exposure. The thesis is falsified if PG delivers sustained unit growth without additional pricing dependence while its valuation premium holds.